Ignite Creation Date:
2024-05-05 @ 12:02 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00217347
Status:
COMPLETED
Last Update Posted:
2008-06-05
First Post:
2005-09-20
Brief Title:
Evaluation of Efficiency of Esophageal Capsule Endoscopy in the Screening of Patients With Gastroesophageal Reflux Disease or Dyspepsia as Compared to Upper Endoscopy
Sponsor:
Nantes University Hospital
Organization:
Nantes University Hospital
Study Overview
Official Title:
None
Status:
COMPLETED
Status Verified Date:
2008-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The exploration of evocative symptoms of esophageal reflux disease or dyspepsia is based on a relatively invasive endoscopic examination often badly tolerated and which in France is carried out in 50 of the cases under general anaesthesia The development of a Capsule Endoscopy of single use of esophageal exploration PILLCAM OESO could allow a painless exploration of the oesophagus without infectious riskThe aim of this study is to validate the information provided by the Esophageal Capsule Endoscopy compared to upper endoscopy in the screening of patients with gastroesophageal reflux disease or dyspepsia For that these patients after being informed and to have given their signed assent will initially have an exploration by Esophageal Capsule Endoscopy and then the very same day or within 3 days maximum a upper endoscopy The information provided by the Esophageal Capsule Endoscopy then by the upper endoscopy will be analyzed by investigators different This study should make it possible to evaluate the parameters of specificity sensitivity and predictive values of Esophageal Capsule Endoscopy in this indication
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None